X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (2584) 2584
Publication (459) 459
Conference Proceeding (52) 52
Book Chapter (38) 38
Book / eBook (20) 20
Paper (16) 16
Magazine Article (8) 8
Book Review (7) 7
Patent (7) 7
Web Resource (6) 6
Dissertation (4) 4
Data Set (2) 2
Newspaper Article (2) 2
Reference (1) 1
Trade Publication Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (591) 591
male (404) 404
index medicus (379) 379
female (354) 354
animals (279) 279
adult (221) 221
middle aged (215) 215
analysis (178) 178
endocrinology & metabolism (178) 178
aged (158) 158
high energy physics - theory (140) 140
biochemistry & molecular biology (138) 138
physics - high energy physics - theory (123) 123
diabetes (105) 105
physics, particles & fields (105) 105
mice (101) 101
theory (101) 101
high energy physics (100) 100
rats (92) 92
adolescent (89) 89
astronomy & astrophysics (83) 83
research (80) 80
insulin (78) 78
physics (74) 74
molecular sequence data (73) 73
multidisciplinary sciences (73) 73
risk factors (71) 71
cell biology (70) 70
glucose (69) 69
models, molecular (67) 67
time factors (67) 67
amino acid sequence (66) 66
treatment outcome (66) 66
astrophysics (65) 65
insulin - metabolism (65) 65
type 2 diabetes (64) 64
àrees temàtiques de la upc (63) 63
expression (61) 61
medicine (61) 61
medicine, general & internal (60) 60
proteins (60) 60
insulin secretion (59) 59
obesity (57) 57
aged, 80 and over (56) 56
binding sites (56) 56
clinical neurology (56) 56
crystallography, x-ray (56) 56
engineering, electrical & electronic (55) 55
high energy astrophysical phenomena (55) 55
spain (55) 55
physiological aspects (54) 54
nutrition & dietetics (53) 53
prevalence (53) 53
islets of langerhans - metabolism (51) 51
cells (50) 50
model (50) 50
crystal-structure (49) 49
risk (49) 49
prevention (48) 48
gamma rays (47) 47
immunology (46) 46
prospective studies (46) 46
follow-up studies (45) 45
gene expression (45) 45
studies (45) 45
activation (44) 44
rats, wistar (44) 44
internal medicine (43) 43
mortality (43) 43
physics - high energy astrophysical phenomena (43) 43
health aspects (42) 42
medicine & public health (42) 42
models (42) 42
biophysics (41) 41
care and treatment (41) 41
physics, applied (41) 41
raigs gamma (41) 41
energy & fuels (40) 40
hypoglycemic agents - therapeutic use (40) 40
mathematics (40) 40
physiology (40) 40
protein (40) 40
article (39) 39
child (39) 39
diabetes mellitus (39) 39
diabetes mellitus, type 2 - drug therapy (39) 39
genes (39) 39
protein conformation (39) 39
wind power (39) 39
breast cancer (38) 38
genetic aspects (38) 38
research article (38) 38
stroke (38) 38
algorithms (37) 37
blood glucose - metabolism (37) 37
chemistry, physical (37) 37
cross-sectional studies (37) 37
metastasis (37) 37
science (37) 37
astrophysics - high energy astrophysical phenomena (36) 36
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Robarts - Stacks (7) 7
UTL at Downsview - May be requested (7) 7
Online Resources - Online (6) 6
Art - Stacks (1) 1
Collection Dvlpm't (Acquisitions) - Cancelled Order (1) 1
Collection Dvlpm't (Acquisitions) - Vendor file (1) 1
Gerstein Science - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (1) 1
UofT at Mississauga - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (2290) 2290
Spanish (285) 285
French (103) 103
Portuguese (25) 25
German (10) 10
Catalan (2) 2
Danish (1) 1
Japanese (1) 1
Lithuanian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 10/2013, Volume 369, Issue 14, pp. 1317 - 1326
Saxagliptin, a new oral antihyperglycemic drug in the DPP-4 inhibitor class, had no effect on the risk of cardiovascular events in patients with type 2... 
ALL-CAUSE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | EVENTS | GLUCOSE CONTROL | MICROALBUMINURIA | DISEASE | CLINICAL-USE | PREVENTION | RISK | DEATH | Dipeptidyl-Peptidase IV Inhibitors - adverse effects | Dipeptidyl-Peptidase IV Inhibitors - therapeutic use | Humans | Middle Aged | Hospitalization - statistics & numerical data | Male | Adamantane - therapeutic use | Aged, 80 and over | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Hypoglycemia - chemically induced | Heart Failure - epidemiology | Diabetes Mellitus, Type 2 - complications | Adamantane - adverse effects | Adamantane - analogs & derivatives | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Dipeptides - therapeutic use | Double-Blind Method | Pancreatitis - epidemiology | Dipeptides - adverse effects | Kaplan-Meier Estimate | Pancreatitis - chemically induced | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Patient outcomes | Dosage and administration | Drug therapy | Heart diseases | Risk factors | Saxagliptin | Myocardial infarction | Cerebral infarction | Heart attacks | Peptidase | Diabetes mellitus | Pancreatitis | Cardiovascular disease | Angina | Patients | Heart rate | Ischemia | Diabetes | Cardiovascular diseases | Diabetes mellitus (non-insulin dependent)
Journal Article
Lancet, The, ISSN 0140-6736, 2013, Volume 382, Issue 9891, pp. 507 - 515
Journal Article
by Gerstein, Hertzel C and Bosch, Jackie and Dagenais, Gilles R and Díaz, Rafael and Jung, Hyejung and Maggioni, Aldo P and Pogue, Janice and Probstfield, Jeffrey and Ramachandran, Ambady and Riddle, Matthew C and Rydén, Lars E and Yusuf, Salim and Richardson, L and Diaz, R and Johnston, P and Vige, R and Birkeland, K and Budaj, A and Cardona, E and Chazova, I and Commerford, P and Danilova, L and Davies, M and Fernando, R and Fodor, G and Gilbert, R and Gomis, R and Hâncu, N and Hanefeld, M and Hildebrandt, P and Kacerovsky-Bielesz, G and Keltai, M and Kim, J.H and Krum, H and Kültürsay, H and Lanas, F and Lewis, B.S and Lonn, E and López-Jaramillo, P and Marin-Neto, J and Marre, M and McKelvie, R and McQueen, M and Mendoza, I and Morillo, C and Pan, C and Pīrāgs, V and Profozic, V and Ratner, R and Richardson, L and Rosenstock, J and Spinas, G.A and Sreenan, S and Stoel, I and Syvänne, M and Yale, J.F and Avezum, A and Bahit, M.C and Bogaty, P and Bordeleau, L and Chacόn, C and Corson, M and Harper, W.L and Halon, D and Magloire, P and Mann, J and Pavlova, V and Punthakee, Z and Silva, J and Tsang, B and Yakubovich, N and Abdallah, A and Ahmad, S and Chandra, J and Chandra, R and Cukierman-Yaffee, T and Dyal, L and Joldersma, L and MacRae, L and MacRae, S and Malik, S and Mead, A and Pasha, F and Pazmino-Canizares, J and Pohl, K and Sakalas, A and Tyrwhitt, J and Ahuad Guerrero, R and Alebuena, A and Alvarez, N and Alzogaray, M and Amuchastegui, M and Andres, M and Angos, M and Baglivo, H and Barbieri, M and Bassi, F and Bello, F and Bono, J and Bustamante Labarta, M and ... and The ORIGIN Trial Investigators and ORIGIN Trial Investigators and Medicinska och farmaceutiska vetenskapsområdet and Uppsala universitet and Medicinska och farmaceutiska vetenskapsområdet, centrumbildningar mm and Centrum för klinisk forskning, Västerås
The New England Journal of Medicine, ISSN 0028-4793, 07/2012, Volume 367, Issue 4, pp. 319 - 328
In this study with a 2-by-2 factorial design, patients with cardiovascular risk factors and dysglycemia or type 2 diabetes received insulin glargine or... 
DIABETES-MELLITUS | MEDICINE, GENERAL & INTERNAL | GLYCEMIC CONTROL | THERAPY | GLARGINE | GLUCOSE CONTROL | DISEASE | RISK | PEOPLE | ENDOTHELIAL FUNCTION | BETA-CELL FUNCTION | Follow-Up Studies | Cardiovascular Diseases - prevention & control | Cholesterol - blood | Humans | Middle Aged | Male | Incidence | Glucose Intolerance - drug therapy | Cardiovascular Diseases - epidemiology | Female | Drug Therapy, Combination | Hypoglycemia - chemically induced | Diabetes Mellitus, Type 2 - complications | Hypoglycemic Agents - therapeutic use | Cardiovascular Diseases - etiology | Fasting | Blood Glucose - analysis | Double-Blind Method | Proportional Hazards Models | Hospitalization | Glucose Intolerance - complications | Insulin, Long-Acting - adverse effects | Insulin Glargine | Insulin, Long-Acting - therapeutic use | Intention to Treat Analysis | Triglycerides - blood | Fatty Acids, Omega-3 - therapeutic use | Aged | Diabetes Mellitus, Type 2 - drug therapy | Hypoglycemic Agents - adverse effects | Type 2 diabetes | Complications and side effects | Care and treatment | Insulin glargine | Patient outcomes | Causes of | Cardiovascular diseases | Risk factors | Myocardial infarction | Fees & charges | Cerebral infarction | Medical research | Stroke | Heart attacks | Statistical analysis | Diabetes mellitus | Glucose | Hypoglycemia | Fatty acids | Insulin | Glucose tolerance | Insulin resistance | Microvasculature | Diabetes | Diabetes mellitus (non-insulin dependent) | Heart diseases | Drug dosages | Cardiovascular Diseases | Insulin, Long-Acting | Blood Glucose | Triglycerides | Glucose Intolerance | Cholesterol | Life Sciences | Hypoglycemic Agents | Diabetes Mellitus, Type 2 | Fatty Acids, Omega-3 | Medical and Health Sciences | Medicin och hälsovetenskap
Journal Article